Invention Grant
- Patent Title: Humanized antibodies that recognize alpha-synuclein
-
Application No.: US16144923Application Date: 2018-09-27
-
Publication No.: US10597441B2Publication Date: 2020-03-24
- Inventor: Jose Saldanha , Tarlochan S. Nijjar
- Applicant: PROTHENA BIOSCIENCES LIMITED
- Applicant Address: IE Dublin
- Assignee: PROTHENA BIOSCIENCES LIMITED
- Current Assignee: PROTHENA BIOSCIENCES LIMITED
- Current Assignee Address: IE Dublin
- Agency: Alston & Bird LLP
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/00 ; A61K49/00 ; A61K49/16 ; A61K51/10
Abstract:
The present application discloses humanized 1H7 antibodies. The antibodies bind to human alpha synuclein and can be used for treatment and diagnosis of Lewy body disease.
Public/Granted literature
- US20190153080A1 Humanized Antibodies That Recognize Alpha-Synuclein Public/Granted day:2019-05-23
Information query
